{"id":3595,"count":102,"description":"Kr\u00e6ftbehandling falder i flere forskellige medicinklasser, hvor hver m\u00e5lretter en anden kr\u00e6ftbiologi \u2014 <strong>hormonterapi<\/strong> (bryst- og prostatakr\u00e6ft), <strong>tyrosinkinaseh\u00e6mmere<\/strong> (kronisk myeloid leuk\u00e6mi, GIST, nyrecellekarcinom, avancerede solide tumorer), <strong>cytotoksisk kemoterapi<\/strong> (alkylerende midler, antimetabolitter), <strong>antiproliferative midler<\/strong> (hydroxyurea), samt <strong>st\u00f8ttende behandlingsmedicin<\/strong> (cancer cachexia, bone-targeted therapy).\n\nMedsBase stocks the major outpatient oral oncology medications. <strong>Aromataseh\u00e6mmere<\/strong> til hormonreceptorpositiv brystkr\u00e6ft (postmenopausale): <strong>Anaridex<\/strong> (anastrozol 1 mg), <strong>Xtane<\/strong> (exemestan 25 mg), <strong>Fempro<\/strong> (letrozol 2,5 mg), <strong>Letroheal<\/strong> (letrozol 2,5 mg). <strong>Tamoxifen (SERM)<\/strong> til pr\u00e6menopausal brystkr\u00e6ft og kvinder med h\u00f8j risiko: <strong>Tamilong<\/strong>, <strong>Tamodex<\/strong>, <strong>Tamoxilon<\/strong>, <strong>Cytotam<\/strong>, <strong>Caditam<\/strong>. <strong>Lapatinib (HER2-m\u00e5lrettet)<\/strong>: <strong>Etibo<\/strong>. <strong>Anti-androgener til fremskreden prostatakr\u00e6ft<\/strong>: <strong>Bdenza<\/strong> (enzalutamid 40 mg), <strong>Bicalumutide<\/strong> (bikalutamid 50 mg), <strong>Cytomid<\/strong> (flutamid 250 mg). <strong>Imatinib (BCR-ABL TKI)<\/strong> til kronisk myeloid leuk\u00e6mi og GIST: <strong>Imat<\/strong>, <strong>Imatib<\/strong>, <strong>Veenat<\/strong>. <strong>Pazopanib (multikinase-TKI)<\/strong> til nyrecellekarcinom og bl\u00f8dv\u00e6vssarkom: <strong>Votrient<\/strong>. <strong>Methotrexat<\/strong> (lav dosis, til b\u00e5de reumatologi og visse leuk\u00e6miformer): <strong>Folitrax<\/strong>, <strong>Imutrex<\/strong>, <strong>Noltrexate<\/strong>, <strong>Leetrexate<\/strong>. <strong>Hydroxyurea<\/strong> (kronisk myeloproliferativ sygdom, seglcellean\u00e6mi): <strong>Hydrosar<\/strong>, <strong>Ondrea<\/strong>, <strong>Riborea<\/strong>. <strong>Orale cytotoksika<\/strong>: <strong>Endoxan<\/strong> (cyclophosphamid), <strong>Celkeran<\/strong> (chlorambucil), <strong>Temotero<\/strong> + <strong>Temozol<\/strong> (temozolomid til gliom), <strong>Lomoother<\/strong> (lomustin). <strong>Endace<\/strong> (megestrol) til cancerkacheksi og palliativ appetitstimulering.\n\n<em>Denne side viser receptpligtige onkologimediciner til ambulant brug. Alle kr\u00e6ftmedicin kr\u00e6ver diagnose, baseline-stadieinddeling og l\u00f8bende tilsyn fra en specialist i onkologi. De fleste har betydelige bivirkninger (myelosuppression, levertoksicitet, embryotoksicitet), l\u00e6gemiddelinteraktioner og kr\u00e6ver regelm\u00e6ssig blodpr\u00f8vekontrol (FBC, LFT, nyrefunktion). Mange er absolut kontraindicerede under graviditet og kr\u00e6ver streng pr\u00e6vention. L\u00e6s den enkelte produktside for fuld doserings-, overv\u00e5gnings- og sikkerhedsinformation, og start, stop eller \u00e6ndr aldrig en kr\u00e6ftmedicin uden din onkologs eksplicitte instruktion.<\/em>","link":"https:\/\/medsbase.com\/da\/anti-cancer-medication\/","name":"Medicin mod kr\u00e6ft","slug":"anti-cancer-medication","taxonomy":"product_cat","parent":3223,"meta":[],"menu_order":0,"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/product_cat\/3595","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/product_cat"}],"about":[{"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/taxonomies\/product_cat"}],"up":[{"embeddable":true,"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/product_cat\/3223"}],"wp:post_type":[{"href":"https:\/\/medsbase.com\/da\/wp-json\/wp\/v2\/product?product_cat=3595"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}